跳至主要内容
临床试验/NCT02587052
NCT02587052已完成不适用

A 1-year Comparison of Generic Tacrolimus (Tacni) and Prograf in Renal Transplant Patients - a Retrospective Matched Pair Analysis

Vastra Gotaland Region1 个研究点 分布在 1 个国家目标入组 186 人开始时间: 2015年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
186
试验地点
1
主要终点
Biopsy-proven acute rejection (BPAR)

研究概览

简要总结

This is a retrospective analysis of two different cohorts of patients that has undergone renal transplantation. This is a matched pair analysis of 100 patients treated with generic tacrolimus that will be compared with 100 matched controls treated with Prograf. Data will be obtained from patients' charts, from the Swedish National Kidney Registry and from a local registry at Transplantationscentrum. Patients included in the study are patients receiving a first single kidney transplant from a deceased or a living donor, treated with Prograf or Tacni and transplanted between transplanted January 2012 and August 2014. The 1-year-outcome of patients following renal transplantation, including BPAR, serious adverse effects and graft survival will be analysed.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients receiving a first single kidney transplant from a deceased or a living donor.
  • Patients treated with Prograf or or generic tacrolimus
  • Patients transplanted between 1 October 2012 and 1 August 2014

排除标准

  • Multi-organ transplants
  • Re-transplantations

研究组 & 干预措施

Tacrolimus

100 patients treated with generic tacrolimus

干预措施: Generic tacrolimus (Drug)

Prograf

100 patients treated with Prograf

干预措施: Prograf (Drug)

结局指标

主要结局

Biopsy-proven acute rejection (BPAR)

时间窗: 1 year

Graft loss

时间窗: 1 year

Death

时间窗: 1 year

次要结局

  • Compare the following parameters in the two groups • Graft survival at 6 and 12 months • BPAR at 6 and 12 months • Calculated GFR at 12 months(6 months, and 1 year)
  • Compare serious adverse events at 12 months in the two groups(1 year)
  • Compare the the cost of admissions for rejection treatment in the two groups(1 year)
  • Tacrolimus dose at day of discharge(day of discharge, approx 7 days)
  • Tacrolimus levels at day of discharge(day of discharge, approx 7 days)

研究者

发起方
Vastra Gotaland Region
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验